Malignant Melanoma
Showing NaN - NaN of 20
Malignant Melanoma Trial in Worldwide (UV1, Sargramostim, Ipilimumab)
Recruiting
- Malignant Melanoma
- UV1
- +3 more
-
Phoenix, Arizona
- +39 more
Aug 16, 2022
Malignant Melanoma Trial in Worldwide (Atezolizumab, Cobimetinib)
Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)
Terminated
- Malignant Melanoma
- +7 more
- Rovalpituzumab tesirine
- Dexamethasone
-
Gilbert, Arizona
- +29 more
Sep 21, 2020
Malignant Melanoma Trial in Worldwide (ABI-007, Dacarbazine)
Completed
- Malignant Melanoma
-
Birmingham, Alabama
- +111 more
Oct 16, 2019
Malignant Melanoma Trial in United States (Coxsackievirus A21 (CVA21))
Completed
- Malignant Melanoma
- Coxsackievirus A21 (CVA21)
-
La Jolla, California
- +9 more
Jun 24, 2019
Malignant Melanoma Trial in United States (HF10 plus Ipilimumab)
Completed
- Malignant Melanoma
- HF10 plus Ipilimumab
-
San Francisco, California
- +7 more
Sep 25, 2018
Malignant Melanoma Trial in United States (Drug cocktail, RO5185426)
Malignant Melanoma Trial in Worldwide (Vemurafenib, Dacarbazine)
Completed
- Malignant Melanoma
-
Birmingham, Alabama
- +110 more
Aug 19, 2016
Malignant Melanoma Trial in Worldwide (HSPPC-96 or Oncophage)
Completed
- Malignant Melanoma
- HSPPC-96 or Oncophage
-
Birmingham, Alabama
- +76 more
Sep 6, 2012
Malignant Melanoma Trial in Worldwide (CancerVax vaccine (CANVAXIN))
Unknown status
- Malignant Melanoma
- CancerVax vaccine (CANVAXIN)
-
Tucson, Arizona
- +79 more
Jun 23, 2005
Malignant Melanoma Trial in Worldwide (CancerVax vaccine (CANVAXIN))
Unknown status
- Malignant Melanoma
- CancerVax vaccine (CANVAXIN)
-
Tucson, Arizona
- +76 more
Jun 23, 2005